Polydopamine Nanoparticles as an Organic and Biodegradable Multitasking Tool for Neuroprotection and Remote Neuronal Stimulation.
Antioxidants
/ chemistry
Apoptosis
/ drug effects
Calcium
/ metabolism
Cell Differentiation
Cell Line, Tumor
Humans
Hyperthermia, Induced
Indoles
/ chemistry
Infrared Rays
Lasers
Models, Biological
Nanoparticles
/ chemistry
Neurons
/ drug effects
Neuroprotection
/ drug effects
Neuroprotective Agents
/ chemistry
Oxidative Stress
/ drug effects
Photothermal Therapy
Polymers
/ chemistry
Reactive Oxygen Species
/ metabolism
Temperature
antioxidant nanoparticles
near-infrared stimulation
neurodegenerative diseases
neuronal stimulation
polydopamine
Journal
ACS applied materials & interfaces
ISSN: 1944-8252
Titre abrégé: ACS Appl Mater Interfaces
Pays: United States
ID NLM: 101504991
Informations de publication
Date de publication:
12 Aug 2020
12 Aug 2020
Historique:
pubmed:
23
7
2020
medline:
17
2
2021
entrez:
23
7
2020
Statut:
ppublish
Résumé
Oxidative stress represents a common issue in most neurological diseases, causing severe impairments of neuronal cell physiological activity that ultimately lead to neuron loss of function and cellular death. In this work, lipid-coated polydopamine nanoparticles (L-PDNPs) are proposed both as antioxidant and neuroprotective agents, and as a photothermal conversion platform able to stimulate neuronal activity. L-PDNPs showed the ability to counteract reactive oxygen species (ROS) accumulation in differentiated SH-SY5Y, prevented mitochondrial ROS-induced dysfunctions and stimulated neurite outgrowth. Moreover, for the first time in the literature, the photothermal conversion capacity of L-PDNPs was used to increase the intracellular temperature of neuron-like cells through near-infrared (NIR) laser stimulation, and this phenomenon was thoroughly investigated using a fluorescent temperature-sensitive dye and modeled from a mathematical point of view. It was also demonstrated that the increment in temperature caused by the NIR stimulation of L-PDNPs was able to produce a Ca
Identifiants
pubmed: 32693584
doi: 10.1021/acsami.0c05497
pmc: PMC8009471
doi:
Substances chimiques
Antioxidants
0
Indoles
0
Neuroprotective Agents
0
Polymers
0
Reactive Oxygen Species
0
polydopamine
0
Calcium
SY7Q814VUP
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
35782-35798Références
J Control Release. 2017 Oct 28;264:306-332
pubmed: 28844756
ACS Chem Neurosci. 2017 Oct 18;8(10):2325-2334
pubmed: 28737894
Biochim Biophys Acta Gen Subj. 2017 Feb;1861(2):386-395
pubmed: 27864151
Adv Healthc Mater. 2020 Feb;9(3):e1901589
pubmed: 31854132
FEBS Lett. 2018 Mar;592(5):728-742
pubmed: 29281123
Nanoscale. 2020 May 7;12(17):9833-9841
pubmed: 32342083
ACS Nano. 2018 Sep 25;12(9):8882-8892
pubmed: 30028940
Nanoscale. 2019 Feb 28;11(9):3855-3863
pubmed: 30758009
Mitochondrion. 2008 Sep;8(4):293-304
pubmed: 18602028
Angew Chem Int Ed Engl. 2017 Nov 6;56(45):14267-14271
pubmed: 28922532
J Neurochem. 2016 May;137(4):506-17
pubmed: 26875993
Nanomedicine. 2015 Oct;11(7):1725-34
pubmed: 26003299
Biomater Sci. 2020 Mar 7;8(5):1345-1363
pubmed: 31912833
Theranostics. 2017 Jul 22;7(12):2996-3006
pubmed: 28839459
ACS Biomater Sci Eng. 2019 Feb 11;5(2):670-682
pubmed: 33405830
Neurochem Int. 2012 Jan;60(2):208-12
pubmed: 22122807
Mol Cell Neurosci. 2006 Dec;33(4):345-57
pubmed: 17000118
ACS Nano. 2010 Oct 26;4(10):6267-77
pubmed: 20925390
Adv Healthc Mater. 2014 Nov;3(11):1862-8
pubmed: 24799427
ACS Nano. 2017 Mar 28;11(3):2494-2508
pubmed: 28107625
Free Radic Biol Med. 2010 Dec 1;49(11):1646-54
pubmed: 20801212
Nanomedicine. 2020 Feb;24:102088
pubmed: 31476446
Nanoscale. 2018 Apr 19;10(15):6981-6991
pubmed: 29610822
Curr Drug Targets. 2014 Apr;15(4):454-68
pubmed: 24428525
FEBS J. 2011 Apr;278(6):941-54
pubmed: 21232014
Biochem Biophys Res Commun. 2013 Jan 25;430(4):1294-300
pubmed: 23261471
Nanomedicine (Lond). 2018 Nov;13(22):2821-2833
pubmed: 30334476
ACS Nano. 2015 Jul 28;9(7):7678-89
pubmed: 26168074
Exp Neurol. 2016 Mar;277:58-67
pubmed: 26626971
Adv Sci (Weinh). 2018 May 09;5(7):1800155
pubmed: 30027047
Pharm Res. 2013 Aug;30(8):2133-45
pubmed: 23661146
Toxicol Sci. 2012 May;127(1):256-68
pubmed: 22367688
Nanoscale. 2011 Apr;3(4):1411-20
pubmed: 21369578
Chem Rev. 2014 May 14;114(9):5057-115
pubmed: 24517847
Cell Metab. 2011 Dec 7;14(6):724-38
pubmed: 22152301
Oxid Med Cell Longev. 2018 Jan 31;2018:6435861
pubmed: 29636850
Biochim Biophys Acta. 2014 Jan;1840(1):495-506
pubmed: 24135455
Nanoscale. 2019 Nov 28;11(44):21227-21248
pubmed: 31663592
Langmuir. 2008 Jul 15;24(14):7354-64
pubmed: 18553993
Biomaterials. 2011 Sep;32(27):6374-80
pubmed: 21652066
Oxid Med Cell Longev. 2017;2017:8416763
pubmed: 28819546
Nanomedicine (Lond). 2017 Feb;12(4):403-416
pubmed: 28000542
ACS Biomater Sci Eng. 2020 Jan 13;6(1):664-672
pubmed: 33463219
Sci Rep. 2014 Oct 21;4:6701
pubmed: 25330751
ACS Omega. 2020 May 14;5(21):12451-12466
pubmed: 32548430
EMBO J. 2006 Aug 23;25(16):3900-11
pubmed: 16874299
J Parkinsons Dis. 2013;3(4):461-91
pubmed: 24252804